CD74

CD74

CD74 Overview

Molecule Name
HLA-DR antigens-associated invariant chain
Synonyms
CD74,DHLAG,HLADG,II,Ia-GAMMA,p33,CLIP,INVG34
Drug Development Progress
Drugs in Clinical Trials5
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
CLIP,CD74,Ia antigen-associated invariant chain,CD74 Molecule,CD74 Antigen (Invariant Polypeptide Of Major Histocompatibility Complex, Class II Antigen-Associated),CD74 Molecule, Major Histocompatibility Complex, Class II Invariant Chain,HLA-DR Antigens-Associated Invariant Chain,Ia-Associated Invariant Chain,MHC HLA-DR Gamma Chain,HLA-DR-Gamma,DHLAG,P33,CD74 Antigen,Ia-GAMMA,HLADG,II,Gamma Chain Of Class II Antigens,HLA Class II Histocompatibility Antigen Gamma Chain
Background
Cluster of Differentiation 74 (CD74) is also known as HLA class II histocompatibility antigen gamma chain (HLADG), DHLAG, Ia-GAMMA, invariant chain (Abbreviated Ii). CD74 / HLADG is a polypeptide involved in the formation and transport of MHC class II protein. The cell surface form of the invariant chain is known as CD74. CD74 is upregulated in several cancers and is also expressed by non-immune cells during inflammation. CD74 plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha / beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal / lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. CD74 / DHLAG also serves as cell surface receptor for the cytokine MIF.

CD74 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Influenza A M1 vaccine (Pascal Biosciences)Phase 1 ClinicalPascal Biosciences
Influenza A virus infections
Details
adenovector based vaccine (Pascal Biosciences/University of British Columbia)Phase 1 ClinicalNevis Brands Inc
Influenza A virus infections
Details
90Y-2IT-BAD-Lym-190Y-2IT-BAD-Lym-1Phase 1 ClinicalNational Cancer Institute
Lymphoma, Non-Hodgkin
Details
Bezetabart debotansineSTRO-001; SP7675; SP-7675; BN-301Phase 1 ClinicalSutro Biopharma Inc
Hematologic Neoplasms; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma
Details
TROP-2-targeted anti-CD74 siRNA (Immunomedics)Immunomedics Inc
Solid tumours
Details